Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Other Non-Current Assets (2016 - 2026)

Nutex Health (NUTX) has disclosed Other Non-Current Assets for 17 consecutive years, with $3.3 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 371.63% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $3.3 million, up 371.63%, while the annual FY2025 figure was $662000.0, 6.89% down from the prior year.
  • Other Non-Current Assets hit $3.3 million in Q1 2026 for Nutex Health, up from $662000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $38.7 million in Q1 2022 and bottomed at $200000.0 in Q1 2023.
  • Average Other Non-Current Assets over 5 years is $2.9 million, with a median of $500000.0 recorded in 2022.
  • Year-over-year, Other Non-Current Assets soared 9445118.05% in 2022 and then crashed 99.48% in 2023.
  • Nutex Health's Other Non-Current Assets stood at $423426.0 in 2022, then increased by 1.82% to $431135.0 in 2023, then skyrocketed by 64.91% to $711000.0 in 2024, then fell by 6.89% to $662000.0 in 2025, then skyrocketed by 397.28% to $3.3 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $3.3 million, $662000.0, and $499000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.